Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

A depressed man turns his head towards someone placing a comforting hand on his shoulder
News
Dementia Linked to Depression Diagnosis at Any Life Stage
08/15/2023
While depression has long been considered one of the first signs of dementia, a recent Danish population cohort study has shown that serious depression diagnosed at any life stage, even in early or mid-life, is associated with an increased...
While depression has long been considered one of the first signs of dementia, a recent Danish population cohort study has shown that serious depression diagnosed at any life stage, even in early or mid-life, is associated with an increased...
While depression has long been...
08/15/2023
Psych Congress Network
A woman with her eyes closed and illustrated brain waves
News
Quality Sleep, Lack of Sleep Apnea Linked With Better Global Cognition
08/15/2023
Better sleep consolidation and the absence of sleep apnea were associated with better global cognition over 5 years in an analysis of middle-aged to older US adults across five independent community-based cohorts.
Better sleep consolidation and the absence of sleep apnea were associated with better global cognition over 5 years in an analysis of middle-aged to older US adults across five independent community-based cohorts.
Better sleep consolidation and...
08/15/2023
Neurology

Advertisement

No Difference in Neurodevelopmental Outcomes With Fetal Antiseizure Drug Exposure
News
No Difference in Neurodevelopmental Outcomes With Fetal Antiseizure Drug Exposure
08/14/2023
Neurodevelopmental outcomes did not differ between 3-year-olds who were exposed to antiseizure medications in utero and their peers who were not exposed, according to a study published in The Lancet Neurology.
Neurodevelopmental outcomes did not differ between 3-year-olds who were exposed to antiseizure medications in utero and their peers who were not exposed, according to a study published in The Lancet Neurology.
Neurodevelopmental outcomes did...
08/14/2023
Neurology
Teens with Headaches Report Increased Rates of Bullying, Suicidality
News
Teens With Headaches Report Increased Rates of Bullying, Suicidality
08/14/2023
Adolescents who have been bullied or who have considered or attempted suicide may be more likely to experience headaches than their peers, according to study results published in Neurology.
Adolescents who have been bullied or who have considered or attempted suicide may be more likely to experience headaches than their peers, according to study results published in Neurology.
Adolescents who have been...
08/14/2023
Neurology
Exercise Combined With Cognitive Training Could Delay Dementia Onset
News
Exercise Combined With Cognitive Training Could Delay Dementia Onset
08/09/2023
Aerobic-resistance exercise and computerized cognitive training could improve cognition in older adults with mild cognitive impairment, according to a randomized clinical trial published in JAMA Network Open. 
Aerobic-resistance exercise and computerized cognitive training could improve cognition in older adults with mild cognitive impairment, according to a randomized clinical trial published in JAMA Network Open. 
Aerobic-resistance exercise and...
08/09/2023
Neurology

Advertisement

Meta-Analysis Finds No Difference in Outcomes With Standard vs Nonstandard PT for PD
News
Meta-Analysis Finds No Difference in Outcomes With Standard vs Nonstandard PT for PD
08/07/2023
A systematic review and meta-analysis of physical therapy (PT) in patients with Parkinson disease (PD) found no significant difference between standard PT and nonstandard PT for balance, gait, and motor outcomes. Researchers published their...
A systematic review and meta-analysis of physical therapy (PT) in patients with Parkinson disease (PD) found no significant difference between standard PT and nonstandard PT for balance, gait, and motor outcomes. Researchers published their...
A systematic review and...
08/07/2023
Neurology
: People At Risk for Alzheimer Disease May Lose Sense of Smell Faster
News
People At Risk for Alzheimer Disease May Lose Sense of Smell Faster
08/03/2023
Those with the APOE e4 gene variant, which has been associated with having the strongest risk of Alzheimer disease, may lose their sense of smell sooner than those without the gene variant, according to a recent study published in Neurology.
Those with the APOE e4 gene variant, which has been associated with having the strongest risk of Alzheimer disease, may lose their sense of smell sooner than those without the gene variant, according to a recent study published in Neurology.
Those with the APOE e4 gene...
08/03/2023
Neurology
An illustration of microbiota
News
For Multiple Sclerosis, First Confirmation That T Cell Activation in Gut Dependent on Microbiome
08/02/2023
For the first time, scientists have charted the activation of gut-based T cells in multiple sclerosis using two-photon imaging in a mouse model. Further, that activation appears to be microbiome-dependent.
For the first time, scientists have charted the activation of gut-based T cells in multiple sclerosis using two-photon imaging in a mouse model. Further, that activation appears to be microbiome-dependent.
For the first time, scientists...
08/02/2023
Neurology

Advertisement

Study IDs New Mechanism Behind Benefit of Exercise in Early Parkinson Disease
News
Study IDs New Mechanism Behind Benefit of Exercise in Early Parkinson Disease
07/31/2023
According to the study, daily treadmill training reduced the spread of toxic alpha-synuclein aggregates in the animals.
According to the study, daily treadmill training reduced the spread of toxic alpha-synuclein aggregates in the animals.
According to the study, daily...
07/31/2023
Neurology
News
CBT Identified as Effective First-Line Treatment for Insomnia in AUD Patients
07/28/2023
A study of veterans with alcohol use disorder found cognitive behavioral therapy outperformed sleep hygiene treatment in reducing insomnia, as well as alcohol consumption, cravings, and associated negative behaviors.
A study of veterans with alcohol use disorder found cognitive behavioral therapy outperformed sleep hygiene treatment in reducing insomnia, as well as alcohol consumption, cravings, and associated negative behaviors.
A study of veterans with alcohol...
07/28/2023
Addiction Professional

Advertisement

Advertisement

News

Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
News
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
11/05/2024
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes...
11/05/2024
Psych Congress Network
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
News
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
11/01/2024
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug...
11/01/2024
Neurology
Gene therapy
News
Concerns Linger After Gene Therapy Shows Long-Term Benefit for Cerebral Adrenoleukodystrophy
10/28/2024
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel...
10/28/2024
Neurology
Patient with family
News
During Recovery, Stroke Patients Benefit from Supportive Social Networks
10/24/2024
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and...
10/24/2024
Neurology
International Stroke Burden Saw Hike Over Last 30 Years
News
International Stroke Burden Saw Hike Over Last 30 Years
10/22/2024
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has...
10/22/2024
Neurology
Hands holding a head in profile with an illustrated heart over brain
News
Antiseizure Meds May Increase Cardiovascular Risk in Older Adults With Epilepsy
10/21/2024
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
A lifetime history of epilepsy...
10/21/2024
Neurology
FDA approval stamp
News
FDA Approves Infusion Treatment for Advanced Parkinson Disease in Adults
10/18/2024
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
AbbVie’s VYALEV (foscarbidopa...
10/18/2024
Neurology
Investigational Drug Improves Motor Function in Patients With SMA
News
Investigational Drug Improves Motor Function in Patients With SMA
10/16/2024
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational...
10/16/2024
Neurology
Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS
News
Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS
10/15/2024
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
Tolebrutinib delayed the time to...
10/15/2024
Neurology
An orange prescription container with generic pills spilling out in front of it
News
Masked Taper Plus CBT for Insomnia Effective in Benzodiazepine Discontinuation
10/10/2024
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined...
10/10/2024
Psych Congress Network

Advertisement

Advertisement

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use